ERBB2 and glioblastoma: In addition, we found that YY1 mRNA expression correlates with the molecular subtypes in BLCA (Non-Papillary vs Papillary; p = 0.049), BRCA (Basal, Her2, Luminal A, Luminal B and Normal-like; p = 9.7011 × 10−9), GBM (Classical, G-CIMP, Mesenchymal, Neural and Proneural; p = 0.046), KIRC (p < 0.0001), LUAD (p = 0.0016), LUSC (p = 0.009), and STAD (p = 0.0012), whereas that of PEBP1 correlates with GBM (p = 0.013), KIRC (p = 2.76 × 10−30), LUAD (subtypes 1–6; p = 0.00005), and LUSC (basal, classical, primitive, and secretory; p = 0.0007) (Figure 1D and Table S3).